Tetrahedron Letters
Bodipy-based photosensitizers with long alkyl tails
at the meso position: efficient singlet oxygen generation
in Cremophor-EL micelles
a
b
c
c
a,b,
⇑
Bilal Kilic , Nisa Yesilgul , Veli Polat , Zuhal Gercek , Engin U. Akkaya
a
UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey
Department of Chemistry, Bilkent University, 06800 Ankara, Turkey
Department of Chemistry, Bulent Ecevit University, 67100 Zonguldak, Turkey
b
c
a r t i c l e i n f o
a b s t r a c t
Article history:
Bodipy dyes with n-decyloxyphenyl-(4, 5) and pentadecyl-(8) meso substituents can easily embed them-
selves into micellar structures formed from Cremophor-EL. In micelles of approximately 20 nm median
size, heavy-atom substituted dyes show remarkable photosensitization properties as evidenced by the
rate of reaction with an anthracene-based selective singlet oxygen trap in buffered aqueous solutions.
Considering the ease of Bodipy derivatization and the advantages of Cremophor-EL carried therapeutic
agents, these photosensitizing agents may offer novel targeting opportunities and enhanced chemical
and photophysical stability.
Received 28 December 2015
Revised 4 February 2016
Accepted 9 February 2016
Available online xxxx
Keywords:
Bodipy
Photosensitizers
Singlet oxygen
Organic chromophores
Organic photochemistry
Ó 2016 Elsevier Ltd. All rights reserved.
Introduction
One of the most effective methods of drug delivery is using lipo-
2
1,22
somal or micellar systems.
In principle it becomes straightfor-
Photodynamic therapy is a promising methodology for the
treatment of certain cancerous and non-cancerous diseases.
ward to include various targeting groups in addition to the active
agent itself into a micellar or liposomal construct. In this work,
we targeted Bodipy derivatives with heavy atom substituents
which would facilitate intersystem crossing. In addition, to ensure
that these compounds would prefer a micellar structure as
opposed to bulk aqueous solution, we incorporated long alkyl
chains at the meso positions (C-8) of the Bodipy dyes. The micelle
forming agent examined was Cremophor EL (Kolliphor EL), a syn-
thetic, non-ionic surfactant made by the reaction of Castor oil
(mostly triglyceride) with ethylene oxide, which provides a poly-
ethylene glycol chain.
1
–8
The treatment protocol involves bringing together three compo-
nents, namely light, molecular oxygen, and a photosensitizer. In
cases where the excited photosensitizer can efficiently undergo
intersystem-crossing to the triplet manifold, excitation energy in
turn, can be transferred to the ground state (triplet) molecular oxy-
gen generating singlet excited molecular oxygen. Singlet oxygen
produced in this way, is the primary cytotoxic agent in photody-
9
namic therapy.
Bodipy-based photosensitizers have received considerable
attention as alternative photosensitizers in recent years.8
,10–14
The
reasons for this attention are twofold: unlike other photostable
Results and discussion
1
5
16,17
dyes such as PDIs and squaraines,
the absorption peak of
these dyes are easily tunable to use the entire visible and even
0
The synthetic plan for 8-alkyl and 8-(4 -alkoxy)aryl derivatives
the near IR region of the spectrum,18 and there are multiple routes
differs to some extent (Scheme 1). p-Hydroxybenzaldehyde was
converted to the corresponding decyl ether by treating it with 1-
bromodecane in acetonitrile at reflux. 4-Decyloxybenzaldehyde
2) was then first treated with 2,4-dimethylpyrrole and TFA in
DCM, followed by oxidation with DDQ. Without isolation, the
dipyrrin intermediate was then treated with Et N and BF O to
1
9,20
to transform these dyes into efficient singlet oxygen generators.
With these considerations, and due to their strong absorptivity in
the visible region, it is clear that Bodipy dyes offer significant poten-
tial comparable to porphyrins and phthalocyanines.
(
3
ꢀEt
3 2
yield the green fluorescent Bodipy dye 3. The 2,6-positions of the
Bodipy core were then brominated and iodinated using different
⇑
040-4039/Ó 2016 Elsevier Ltd. All rights reserved.
0